scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.2215/CJN.04071206 |
P8608 | Fatcat ID | release_wnz7xf7zybgztl4nkgrkih7q3q |
P698 | PubMed publication ID | 17699463 |
P2093 | author name string | Robert H Mak | |
Ihab M Wahba | |||
P433 | issue | 3 | |
P921 | main subject | obesity | Q12174 |
metabolic syndrome | Q657193 | ||
P304 | page(s) | 550-562 | |
P577 | publication date | 2007-03-14 | |
P1433 | published in | Clinical Journal of the American Society of Nephrology | Q15757929 |
P1476 | title | Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease | |
P478 | volume | 2 |
Q27331760 | A blueberry-enriched diet improves renal function and reduces oxidative stress in metabolic syndrome animals: potential mechanism of TLR4-MAPK signaling pathway |
Q64970867 | A novel resveratrol analog PA19 attenuates obesity‑induced cardiac and renal injury by inhibiting inflammation and inflammatory cell infiltration. |
Q55456109 | A novel vibration-induced exercise paradigm improves fitness and lipid metabolism of Caenorhabditis elegans. |
Q30978054 | A single nucleotide polymorphism within the acetyl-coenzyme A carboxylase beta gene is associated with proteinuria in patients with type 2 diabetes |
Q63440925 | ACACβ gene (rs2268388) and AGTR1 gene (rs5186) polymorphism and the risk of nephropathy in Asian Indian patients with type 2 diabetes |
Q35012428 | ACE inhibition is renoprotective among obese patients with proteinuria |
Q35818630 | Abdominal Adipose Tissue was Associated with Glomerular Hyperfiltration among Non- Diabetic and Normotensive Adults with a Normal Body Mass Index |
Q36179961 | Accelerated renal disease is associated with the development of metabolic syndrome in a glucolipotoxic mouse model. |
Q26798068 | Alteration of Fatty Acid Oxidation in Tubular Epithelial Cells: From Acute Kidney Injury to Renal Fibrogenesis |
Q46929763 | Angiotensin 1-7 mediates renoprotection against diabetic nephropathy by reducing oxidative stress, inflammation, and lipotoxicity |
Q34979668 | Angiotensin type 1 receptor modulates macrophage polarization and renal injury in obesity |
Q28730621 | Anthropomorphic measurements that include central fat distribution are more closely related with key risk factors than BMI in CKD stage 3 |
Q98290844 | Anti-obesity effect of a hop-derived prenylflavonoid isoxanthohumol in a high-fat diet-induced obese mouse model |
Q36909985 | Antidiabetic and Antinephritic Activities of Aqueous Extract of Cordyceps militaris Fruit Body in Diet-Streptozotocin-Induced Diabetic Sprague Dawley Rats |
Q41536906 | Association Between Body Mass Index Combined with Albumin: creatinine Ratio and All-cause Mortality in Chinese Population |
Q85008903 | Association between prehypertension and chronic kidney disease in the Japanese general population |
Q44451538 | Association of body mass index with glomerular filtration rate in Japanese: a cross-sectional study in work-site population. |
Q28660741 | Association of metabolic syndrome with kidney function and histology in living kidney donors |
Q50135660 | Association of physical capacity with heart rate variability based on a short-duration measurement of resting pulse rate in older adults with obesity |
Q35117283 | Association of visceral adiposity with increased intrarenal artery resistive index in HIV-1-infected patients receiving highly active antiretroviral therapy |
Q37521278 | Astragaloside IV Attenuates Podocyte Apoptosis Mediated by Endoplasmic Reticulum Stress through Upregulating Sarco/Endoplasmic Reticulum Ca2+-ATPase 2 Expression in Diabetic Nephropathy |
Q35070137 | Attenuation of hyperlipidemia- and diabetes-induced early-stage apoptosis and late-stage renal dysfunction via administration of fibroblast growth factor-21 is associated with suppression of renal inflammation |
Q47255994 | Bariatric Surgery can Reduce Albuminuria in Patients with Severe Obesity and Normal Kidney Function by Reducing Systemic Inflammation |
Q37843766 | Bariatric surgery and renal function |
Q51263117 | Body mass index and annual estimated GFR decline in Chinese adults with normal renal function. |
Q87289944 | Body mass index and preclinical kidney disease in Indian adults aged 40 years and above without chronic kidney disease |
Q44065003 | Body mass index trend in haemodialysis patients: the shift of nutritional disorders in two Italian regions |
Q55212252 | Bowman Capsule Volume and Related Factors in Adults With Normal Renal Function. |
Q36556374 | Caffeic Acid Phenethyl Ester Regulates PPAR's Levels in Stem Cells-Derived Adipocytes |
Q58557762 | Can childhood obesity influence later chronic kidney disease? |
Q86553719 | Chapter 3: Management of progression and complications of CKD |
Q86553726 | Chapter 5: Referral to specialists and models of care |
Q38171244 | Clinical biomarkers in metabolic syndrome |
Q41843005 | Clinical epidemiology of reduced kidney function among elderly male fishing and agricultural population in Taipei, Taiwan |
Q41420644 | Coenzyme Q10 Improves Lipid Metabolism and Ameliorates Obesity by Regulating CaMKII-Mediated PDE4 Inhibition |
Q53793103 | Combined body mass index with high-sensitivity C-reactive protein as independent predictors for chronic kidney disease in a relatively healthy population in Taiwan. |
Q90655360 | Comparison of high-fat style diet-induced dysregulation of baroreflex control of renal sympathetic nerve activity in intact and ovariectomized female rats: Renal sympathetic nerve activity in high-fat style diet fed intact and ovariectomized female |
Q99709046 | Complement Properdin Regulates the Metabolo-Inflammatory Response to a High Fat Diet |
Q47302626 | Compliance with a structured weight loss program is associated with reduced systolic blood pressure in obese patients with chronic kidney disease |
Q37511029 | Consequences of morbid obesity on the kidney. Where are we going? |
Q38320900 | Correlation of ultrasonographic measurement of intrarenal arterial resistance index with microalbuminuria in nonhypertensive, nondiabetic obese patients |
Q36763648 | Correlation of visceral adiposity index with chronic kidney disease in the People's Republic of China: to rediscover the new clinical potential of an old indicator for visceral obesity |
Q40142078 | Cyanidin-3-glucoside increases whole body energy metabolism by upregulating brown adipose tissue mitochondrial function |
Q34270500 | DPP4 inhibition attenuates filtration barrier injury and oxidant stress in the zucker obese rat |
Q90748230 | Defective Mitochondrial Fatty Acid Oxidation and Lipotoxicity in Kidney Diseases |
Q35610072 | Diabetes mellitus and the risk of urolithiasis: a meta-analysis of observational studies |
Q36951243 | Diabetes mellitus as a cause of end-stage renal disease in Europe: signs of improvement |
Q41630778 | Early development of podocyte injury independently of hyperglycemia and elevations in arterial pressure in nondiabetic obese Dahl SS leptin receptor mutant rats |
Q44896182 | Early improvement in albuminuria in non-diabetic patients after Roux-en-Y bariatric surgery |
Q28547970 | Effect of Acetazolamide on Obesity-Induced Glomerular Hyperfiltration: A Randomized Controlled Trial |
Q40228971 | Effect of Different Obesity Phenotypes on Incidence of Chronic Kidney Disease in Tehranian Adults |
Q39079610 | Effect of a High-Protein Energy-Restricted Diet Combined with Resistance Training on Metabolic Profile in Older Individuals with Metabolic Impairments |
Q99569227 | Effect of dapagliflozin as an adjunct to insulin over 52 weeks in individuals with type 1 diabetes: post-hoc renal analysis of the DEPICT randomised controlled trials |
Q33818281 | Effect of renal lipid accumulation on proximal tubule Na+/H+ exchange and ammonium secretion |
Q36152742 | Effects of Bariatric Surgery on Renal Function in Obese Patients: A Systematic Review and Meta Analysis |
Q36047552 | Effects of metabolic syndrome on kidney transplantation outcomes: a systematic review and meta-analysis. |
Q46879565 | Erythrocyte osmotic fragility and general health status of adolescent Sprague Dawley rats supplemented with Hibiscus sabdariffa aqueous calyx extracts as neonates followed by a high-fructose diet post-weaning. |
Q37677727 | Estimating Negative Effect of Abdominal Obesity on Mildly Decreased Kidney Function Using a Novel Index of Body-Fat Distribution. |
Q46839837 | Evaluation of microalbuminuria in obese children and its relation to metabolic syndrome |
Q38209300 | Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease |
Q64093630 | Fluvastatin Sodium Ameliorates Obesity through Brown Fat Activation |
Q64229549 | Gender- and Age-Specific Associations between Visceral Obesity and Renal Function Impairment |
Q34043086 | Ghrelin in chronic kidney disease |
Q37575609 | Ginsenoside Rg1 suppresses early stage of adipocyte development via activation of C/EBP homologous protein-10 in 3T3-L1 and attenuates fat accumulation in high fat diet-induced obese zebrafish |
Q47106733 | Glomerulopathy Associated With Moderate Obesity. |
Q45809817 | Grape seed and skin extract alleviates high-fat diet-induced renal lipotoxicity and prevents copper depletion in rat. |
Q90178919 | High levels of fasting glucose and glycosylated hemoglobin values are associated with hyperfiltration in a Spanish prediabetes cohort. The PREDAPS Study |
Q37066329 | High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation |
Q37734623 | Higher glomerular filtration rate is related to insulin resistance but not to obesity in a predominantly obese non-diabetic cohort. |
Q37709360 | Hypertension and obesity after pediatric kidney transplantation: management based on pathophysiology: a mini review |
Q35129384 | Hypertriglyceridemic waist phenotype and chronic kidney disease in a Chinese population aged 40 years and older |
Q36946421 | Impact of Type 2 Diabetes on Impaired Kidney Function in Sub-Saharan African Populations |
Q39631387 | Impact of metabolic syndrome on the incidence of chronic kidney disease: a Chinese cohort study |
Q90421219 | Impact of obesity as an independent risk factor for the development of renal injury: implications from rat models of obesity |
Q35567862 | Impact of obesity on kidney function and blood pressure in children |
Q37563980 | Impact of treating the metabolic syndrome on chronic kidney disease |
Q57718011 | Implications for kidney disease in obese children and adolescents |
Q40468739 | Improvement in liver histology due to lifestyle modification is independently associated with improved kidney function in patients with non-alcoholic steatohepatitis. |
Q35543224 | Increased glomerular filtration rate in early metabolic syndrome is associated with renal adiposity and microvascular proliferation |
Q35904102 | Inflammation and oxidative stress in obesity-related glomerulopathy |
Q40188954 | Inflammatory stress promotes the development of obesity-related chronic kidney disease via CD36 in mice |
Q36967815 | Insulin and its role in chronic kidney disease |
Q34018585 | Interaction of aldosterone and extracellular volume in the pathogenesis of obesity-associated kidney disease: a narrative review |
Q37148712 | Intrarenal renin-angiotensin system mediates fatty acid-induced ER stress in the kidney |
Q33597287 | Inverse associations between androgens and renal function: the Young Men Cardiovascular Association (YMCA) study |
Q43187650 | Involvement of visceral fat in the pathogenesis of albuminuria in patients with type 2 diabetes with early stage of nephropathy |
Q90050056 | Irisin Exerts Inhibitory Effect on Adipogenesis Through Regulation of Wnt Signaling |
Q38059630 | Is obesity a risk factor for chronic kidney disease in children? |
Q37068381 | Kidney function in obese adolescents with or without metabolic syndrome in a nationally-representative sample of pediatric population: First report from the Middle East and North Africa: The CASPIAN-III Study: A Case-Control Study |
Q40443314 | Kidney outcomes three years after bariatric surgery in severely obese adolescents. |
Q35695693 | Left ventricular global longitudinal strain is associated with cardiovascular risk factors and arterial stiffness in chronic kidney disease |
Q92671897 | Left ventricular mass index and subendocardial myocardial function in children with chronic kidney disease, a transmural strain and three-dimensional echocardiographic study |
Q37182203 | Lifestyle-induced metabolic inflexibility and accelerated ageing syndrome: insulin resistance, friend or foe? |
Q37980001 | Lipid nephrotoxicity: new concept for an old disease |
Q38289344 | Lipidomic analysis reveals significant lipogenesis and accumulation of lipotoxic components in ob/ob mouse organs |
Q55223580 | Long-term risk for end-stage kidney disease and death in a large population-based cohort. |
Q50967646 | Longitudinal relationships of metabolic syndrome and obesity with kidney function: Healthy Twin Study. |
Q33812172 | MRI-determined fat content of human liver, pancreas and kidney |
Q38751663 | Maladaptive Cardiac Autonomic Control during a Stress Reactivity Assessment Among Primary Care Patients with Metabolic Syndrome. |
Q27027141 | Management of obesity-induced kidney disease: a critical review of the literature |
Q36654960 | Medaka fish, Oryzias latipes, as a model for human obesity-related glomerulopathy |
Q56394611 | Metabolic Syndrome Severity and Risk of CKD and Worsened GFR: The Jackson Heart Study |
Q84960392 | Metabolic Syndrome and Chronic Kidney Disease |
Q38137667 | Metabolic syndrome and associated chronic kidney diseases: nutritional interventions |
Q34453266 | Metabolic syndrome and chronic kidney disease: Current status and future directions |
Q84573076 | Metabolic syndrome and urinary stone composition: what factors matter most? |
Q42757693 | Metabolic syndrome and urologic diseases |
Q40954876 | Metabolic syndrome does not always play a critical role in decreased GFR. |
Q36910935 | Metabolic syndrome, ESRD, and death in CKD. |
Q87935711 | Metabolically Healthy Obesity and Risk of Kidney Function Decline |
Q33907267 | Metabolically healthy obesity: a friend or foe? |
Q54264269 | Mild alcohol intake exacerbates metabolic syndrome in rodents: a putative role of GSK-3β. |
Q35126070 | Multiple low-dose radiation prevents type 2 diabetes-induced renal damage through attenuation of dyslipidemia and insulin resistance and subsequent renal inflammation and oxidative stress |
Q37257080 | Neck circumference predicts renal function decline in overweight women: A community-based prospective cohort study. |
Q37161462 | New aspects of the relationship among hypertension, obesity, and the kidneys |
Q46593121 | Nicotine Enhances High-Fat Diet-Induced Oxidative Stress in the Kidney |
Q35282636 | Nicotinic acetylcholine receptor α1 promotes calpain-1 activation and macrophage inflammation in hypercholesterolemic nephropathy |
Q54420633 | Nlrp3 is a key modulator of diet-induced nephropathy and renal cholesterol accumulation. |
Q83341713 | Obesity and preterm birth: additive risks in the progression of kidney disease in children |
Q35958492 | Obesity and renovascular disease |
Q46941041 | Obesity and synergistic risk factors for chronic kidney disease in African American adults: the Jackson Heart Study |
Q37335044 | Obesity, inflammation, and kidney disease. |
Q36275424 | Obesity-induced chronic inflammation in high fat diet challenged C57BL/6J mice is associated with acceleration of age-dependent renal amyloidosis |
Q37093643 | Obesity-metabolic derangement preserves hemodynamics but promotes intrarenal adiposity and macrophage infiltration in swine renovascular disease |
Q38122630 | Obesity-related glomerulopathy and the nephron complement |
Q38837343 | Occupational exposure to respirable crystalline silica and chronic non-malignant renal disease: systematic review and meta-analysis. |
Q35928484 | Overweight, obesity and intentional weight loss in chronic kidney disease: NHANES 1999-2006. |
Q34589532 | Parathyroid hormone is a plausible mediator for the metabolic syndrome in the morbidly obese: a cross-sectional study |
Q33551642 | Pediatric Metabolic Syndrome: Pathophysiology and Laboratory Assessment |
Q81360568 | Pediatric nephrology patients are overweight: 20 years' experience in a single Canadian tertiary pediatric nephrology clinic |
Q30829502 | Physical activity and metabolic health in chronic kidney disease: a cross-sectional study |
Q64068145 | Post-weaning Exposure to High-Fat Diet Induces Kidney Lipid Accumulation and Function Impairment in Adult Rats |
Q47393085 | Potential impact of renin-angiotensin system inhibitors and calcium channel blockers on plasma high-molecular-weight adiponectin levels in hemodialysis patients |
Q37869829 | Potential nutritional conflicts in bariatric and renal transplant patients. |
Q84593608 | Prevalence of chronic kidney disease in China |
Q64081008 | Prevalence of metabolic syndrome in dialysis and transplant patients |
Q33610654 | Prevention of obesity-induced renal injury in male mice by DPP4 inhibition |
Q37601862 | Proteinuria in Apparently Healthy Elderly Dogs: Persistency and Comparison Between Free Catch and Cystocentesis Urine |
Q37360338 | Proteomic and phosphoproteomic analysis of renal cortex in a salt-load rat model of advanced kidney damage |
Q35005734 | Proximal tubular hypertrophy and enlarged glomerular and proximal tubular urinary space in obese subjects with proteinuria |
Q34936316 | Recent advances in the pathophysiology of nephrolithiasis |
Q84435652 | Recovery of renal function in a dialysis-dependent patient following gastric bypass surgery |
Q34998284 | Reduction of renal triglyceride accumulation: effects on proximal tubule Na+/H+ exchange and urinary acidification |
Q93609219 | References |
Q34211573 | Regulation of podocyte survival and endoplasmic reticulum stress by fatty acids |
Q34362642 | Relationship between Kidney Function and Liver Histology in Subjects with Nonalcoholic Steatohepatitis |
Q35896622 | Relationship between body mass index and proteinuria in hypertensive nephrosclerosis: results from the African American Study of Kidney Disease and Hypertension (AASK) cohort |
Q49949093 | Renal fat fraction and diffusion tensor imaging in patients with early-stage diabetic nephropathy |
Q37022748 | Renal function following three distinct weight loss dietary strategies during 2 years of a randomized controlled trial |
Q34825296 | Renal lipid metabolism and lipotoxicity |
Q30360386 | Renal outcomes of bariatric surgery in obese adults with diabetic kidney disease. |
Q38842693 | Renoprotective effect of a combination of garlic and telmisartan against ischemia/reperfusion-induced kidney injury in obese rats |
Q35664491 | Risk factors and their interaction on chronic kidney disease: A multi-centre case control study in Taiwan |
Q24610857 | Role of nuclear receptor corepressor RIP140 in metabolic syndrome |
Q24594814 | Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspective |
Q41699701 | Sagittal abdominal diameter as an anthropometric measure of cardiovascular and graft loss risk in renal transplant recipients |
Q64078970 | Serum klotho is inversely associated with metabolic syndrome in chronic kidney disease: results from the KNOW-CKD study |
Q44634038 | Sex influences the effect of body mass index on the vascular response to angiotensin II in humans. |
Q38825855 | Simvastatin attenuates oleic acid-induced oxidative stress through CREB-dependent induction of heme oxygenase-1 in renal proximal tubule cells |
Q37683444 | Sleep duration and chronic kidney disease: The Korean Genome and Epidemiology Study (KoGES)-Kangwha study |
Q50588263 | Smad3 deficiency protects mice from obesity-induced podocyte injury that precedes insulin resistance. |
Q38510757 | The ACACB gene rs2268388 polymorphism is associated with nephropathy in Caucasian patients with diabetes: a meta-analysis |
Q47136838 | The Renal Pathology of Obesity |
Q37924425 | The Western-style diet: a major risk factor for impaired kidney function and chronic kidney disease |
Q38254887 | The association between lipid metabolism gene polymorphisms and nephropathy in type 2 diabetes: a meta-analysis |
Q42201543 | The effect of obesity and type 1 diabetes on renal function in children and adolescents |
Q33570124 | The farnesoid X receptor modulates renal lipid metabolism and diet-induced renal inflammation, fibrosis, and proteinuria |
Q37148305 | The influence of body composition on renal function in patients with coronary artery disease and its prognostic significance: a retrospective cohort study |
Q41644342 | The risk of chronic kidney disease in a metabolically healthy obese population |
Q36250127 | The role of nuclear receptors in the kidney in obesity and metabolic syndrome |
Q39180146 | Three-year incidence of elevated albuminuria and associated factors in a population-based cohort: The Taichung Community Health Study |
Q38187597 | Treatment strategies to prevent renal damage in hypertensive children |
Q37917648 | Uric acid: a starring role in the intricate scenario of metabolic syndrome with cardio-renal damage? |
Q34639560 | Urinary Cystatin C as a Potential Risk Marker for Cardiovascular Disease and Chronic Kidney Disease in Patients with Obesity and Metabolic Syndrome |
Q37395121 | Urinary Netrin-1: A New Biomarker for the Early Diagnosis of Renal Damage in Obese Children |
Q33937580 | Urinary albumin excretion, HMW adiponectin, and insulin sensitivity in type 2 diabetic patients undergoing bariatric surgery |
Q89883916 | Visceral Adiposity Index and Chronic Kidney Disease in a Non-Diabetic Population: A Cross-Sectional Study |
Q55019846 | Weight loss has an additive effect on the proteinuria reduction of angiotensin II receptor blockers in hypertensive patients with chronic kidney disease. |
Q35006811 | Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis |
Q37465201 | Wnt5a induces renal AQP2 expression by activating calcineurin signalling pathway. |
Search more.